pan-kinase inhibitor (Cancer Therapeutics CRC)

N/A

Report date: 2025/03/20 09:13:55
NME

Base Information

Drug Namepan-kinase inhibitor (Cancer Therapeutics CRC)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases inhibitors
TargetsProtein kinases
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCancer Therapeutics CRC Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCancer Therapeutics CRC Pty Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A